Literature DB >> 21732220

Characterization of microchannels created by metal microneedles: formation and closure.

Haripriya Kalluri1, Chandra Sekhar Kolli, Ajay K Banga.   

Abstract

Transdermal delivery of therapeutic agents for cosmetic therapy is limited to small and lipophilic molecules by the stratum corneum barrier. Microneedle technology overcomes this barrier and offers a minimally invasive and painless route of administration. DermaRoller(®), a commercially available handheld device, has metal microneedles embedded on its surface which offers a means of microporation. We have characterized the microneedles and the microchannels created by these microneedles in a hairless rat model, using models with 370 and 770 μm long microneedles. Scanning electron microscopy was employed to study the geometry and dimensions of the metal microneedles. Dye binding studies, histological sectioning, and confocal microscopy were performed to characterize the created microchannels. Recovery of skin barrier function after poration was studied via transepidermal water loss (TEWL) measurements, and direct observation of the pore closure process was investigated via calcein imaging. Characterization studies indicate that 770 μm long metal microneedles with an average base width of 140 μm and a sharp tip with a radius of 4 μm effectively created microchannels in the skin with an average depth of 152.5 ± 9.6 μm and a surface diameter of 70.7 ± 9.9 μm. TEWL measurements indicated that skin regains it barrier function around 4 to 5 h after poration, for both 370 and 770 μm microneedles. However, direct observation of pore closure, by calcein imaging, indicated that pores closed by 12 h for 370 μm microneedles and by 18 h for 770 μm microneedles. Pore closure can be further delayed significantly under occluded conditions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732220      PMCID: PMC3160154          DOI: 10.1208/s12248-011-9288-3

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  30 in total

1.  Lack of pain associated with microfabricated microneedles.

Authors:  S Kaushik; A H Hord; D D Denson; D V McAllister; S Smitra; M G Allen; M R Prausnitz
Journal:  Anesth Analg       Date:  2001-02       Impact factor: 5.108

Review 2.  Iontophoretic drug delivery.

Authors:  Yogeshvar N Kalia; Aarti Naik; James Garrison; Richard H Guy
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

Review 3.  Microneedles for transdermal drug delivery.

Authors:  Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

Review 4.  Ultrasound-induced cavitation: applications in drug and gene delivery.

Authors:  Sumit Paliwal; Samir Mitragotri
Journal:  Expert Opin Drug Deliv       Date:  2006-11       Impact factor: 6.648

5.  Microfabricated microneedles: a novel approach to transdermal drug delivery.

Authors:  S Henry; D V McAllister; M G Allen; M R Prausnitz
Journal:  J Pharm Sci       Date:  1998-08       Impact factor: 3.534

6.  Microneedles in clinical practice--an exploratory study into the opinions of healthcare professionals and the public.

Authors:  James C Birchall; Rachel Clemo; Alexander Anstey; Dai N John
Journal:  Pharm Res       Date:  2010-03-18       Impact factor: 4.200

7.  Functional and structural changes of the epidermal barrier induced by various types of insults in hairless mice.

Authors:  S K Ahn; S J Jiang; S M Hwang; E H Choi; J S Lee; S H Lee
Journal:  Arch Dermatol Res       Date:  2001-06       Impact factor: 3.017

8.  Characterization of solid maltose microneedles and their use for transdermal delivery.

Authors:  Chandra Sekhar Kolli; Ajay K Banga
Journal:  Pharm Res       Date:  2007-06-28       Impact factor: 4.200

9.  Acne scarring treatment using skin needling.

Authors:  G Fabbrocini; N Fardella; A Monfrecola; I Proietti; D Innocenzi
Journal:  Clin Exp Dermatol       Date:  2009-05-22       Impact factor: 3.470

10.  Effect of microneedle design on pain in human volunteers.

Authors:  Harvinder S Gill; Donald D Denson; Brett A Burris; Mark R Prausnitz
Journal:  Clin J Pain       Date:  2008-09       Impact factor: 3.442

View more
  26 in total

1.  Intradermal delivery of a fractional dose of influenza H7N9 split vaccine elicits protective immunity in mice and rats.

Authors:  Shanshan Zhou; Tianyu Ren; Hongjing Gu; Cheng Wang; Min Li; Zhongpeng Zhao; Li Xing; Liangyan Zhang; Yi Sun; Penghui Yang; Xiliang Wang
Journal:  Hum Vaccin Immunother       Date:  2018-02-12       Impact factor: 3.452

Review 2.  Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation.

Authors:  Rebecca E M Lutton; Jessica Moore; Eneko Larrañeta; Stephen Ligett; A David Woolfson; Ryan F Donnelly
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

3.  Hydrogel-forming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected.

Authors:  Ryan F Donnelly; Karen Mooney; Maelíosa T C McCrudden; Eva M Vicente-Pérez; Luc Belaid; Patricia González-Vázquez; James C McElnay; A David Woolfson
Journal:  J Pharm Sci       Date:  2014-03-14       Impact factor: 3.534

4.  Impact-insertion applicator improves reliability of skin penetration by solid microneedle arrays.

Authors:  Koen van der Maaden; Emine Sekerdag; Wim Jiskoot; Joke Bouwstra
Journal:  AAPS J       Date:  2014-04-24       Impact factor: 4.009

5.  Delivery of Methotrexate and Characterization of Skin Treated by Fabricated PLGA Microneedles and Fractional Ablative Laser.

Authors:  Hiep X Nguyen; Ajay K Banga
Journal:  Pharm Res       Date:  2018-02-21       Impact factor: 4.200

6.  Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet.

Authors:  Ryan F Donnelly; Kurtis Moffatt; Ahlam Zaid Alkilani; Eva M Vicente-Pérez; Johanne Barry; Maelíosa T C McCrudden; A David Woolfson
Journal:  Pharm Res       Date:  2014-02-19       Impact factor: 4.200

7.  Methimazole in the Treatment of Melasma: A Clinical and Dermascopic Study.

Authors:  Azza Farag; Mostafa Hammam; Nada Alnaidany; Eman Badr; Mustafa Elshaib; Aliaa El-Swah; Wafaa Shehata
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

Review 8.  Microneedles for drug and vaccine delivery.

Authors:  Yeu-Chun Kim; Jung-Hwan Park; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2012-05-01       Impact factor: 15.470

9.  Mesenchymal Stromal Cell-derived Extracellular Vesicles in Preclinical Animal Models of Tumor Growth: Systematic Review and Meta-analysis.

Authors:  Adrian J M Bailey; Alvin Tieu; Manika Gupta; Mitchell Slobodian; Risa Shorr; Tim Ramsay; Rosendo A Rodriguez; Dean A Fergusson; Manoj M Lalu; David S Allan
Journal:  Stem Cell Rev Rep       Date:  2021-04-15       Impact factor: 5.739

10.  Micropore Closure Rates following Microneedle Application at Various Anatomical Sites in Healthy Human Subjects.

Authors:  Abayomi Tolulope Ogunjimi; Christine Lawson; Jamie Carr; Krishna Kumar Patel; Nkanyezi Ferguson; Nicole K Brogden
Journal:  Skin Pharmacol Physiol       Date:  2021-04-28       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.